As of Jul 20
| +0.01 / +0.10%|
The 2 analysts offering 12-month price forecasts for Osiris Therapeutics Inc have a median target of 8.00, with a high estimate of 12.00 and a low estimate of 4.00. The median estimate represents a -19.60% decrease from the last price of 9.95.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.